e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BMRN
Recent news which mentions BMRN
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
September 07, 2021
Tickers
ADAP
APOP
BMRN
FWP
Tags
FWP
Movers
IPHA
From
Benzinga
FDA Slaps Clinical Hold on BioMarin's Gene Therapy For Genetic Metabolism Disorder
September 07, 2021
Tickers
BMRN
Tags
BMRN
Biotech
gene therapy
From
Benzinga
Drug For Short-Limbed Dwarfism From Biomarin Wins European Approval
August 27, 2021
Tickers
BMRN
Tags
achondroplasia
General
Market News
From
Benzinga
Get Ready for a Potential Double in This Biopharmaceutical Stock in the Next 6 to 12 Months
August 20, 2021
Tickers
ASND
BMRN
Tags
Market News
ASND
BMRN
From
Motley Fool
BioMarin Bounces Back With Solid Q2 Earnings, Nudges Up 2021 Guidance
July 29, 2021
Tickers
BMRN
Tags
News
Market News
Health Care
From
Benzinga
BioMarin Pharmaceutical inc (BMRN) Q2 2021 Earnings Call Transcript
July 29, 2021
Tickers
BMRN
Tags
BMRN
Market News
From
Motley Fool
Biomarin Pharmaceutical: Q2 Earnings Insights
July 28, 2021
Tickers
BMRN
Tags
Benzinga
Market News
Earnings
From
Benzinga
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
July 28, 2021
Tickers
ABCL
ABOS
ACET
ACHL
Tags
ESPR
EPZM
BSX
From
Benzinga
The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More
July 25, 2021
Tickers
ABBV
ACIU
AGIO
AGRX
Tags
AGIO
VRTX
ANVS
From
Benzinga
BioMarin Shares 5-Year Data From Open-Label Trial Of Hemophilia Gene Therapy
July 21, 2021
Tickers
BMRN
Tags
Phase 2 Trial
Briefs
BMRN
From
Benzinga
BioMarin Expects EMA's CHMP Opinion In 1H 2022 For Its Hemophilia A Gene Therapy, FDA Resubmission In 2Q'22
July 15, 2021
Tickers
BMRN
Tags
BMRN
Biotech
gene therapy
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.